LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy

Assessment of extracranial metastatic disease in patients with brain metastases: How much effort is needed in the context of evolving survival prediction models?

“…In most retrospective studies, assessment of radiological and laboratory work-up has not been standardized [17,18]. Despite such inconsistency, e.g., serum biomarkers such as lactate dehydrogenase and albumin have emerged as prognostically relevant and inexpensive baseline staging parameters, but are not universally obtained or reported [17][18][19][20].…”